Emerging roles of claudins in human cancer

Mi Jeong Kwon1

  • 1College of Pharmacy, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu 702-701, Korea. mjkwon94@knu.ac.kr

Insights

Claudins, proteins in tight junctions, are linked to cancer progression and recurrence. Targeting claudins may offer new treatments for chemoresistant and recurrent tumors.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Claudins are integral membrane proteins crucial for tight junctions.
  • Altered expression of specific claudins (e.g., claudin-1, -3, -4, -7) is associated with various cancers.
  • The precise mechanisms of claudin involvement in tumorigenesis are still under investigation.

Purpose of the Study:

  • To explore the role of claudins in cancer progression, including migration, invasion, and metastasis.
  • To investigate the involvement of claudins in epithelial to mesenchymal transition (EMT), cancer stem cells (CSCs), and chemoresistance.
  • To highlight claudins as potential therapeutic targets for recurrent and chemoresistant tumors.

Main Methods:

  • Review of recent studies on claudin expression and function in cancer.
  • Analysis of the association between claudin-low breast cancer subtype and disease recurrence.
  • Exploration of epigenetic regulation of claudin expression.

Main Results:

  • Claudins play a significant role in cancer cell migration, invasion, and metastasis in a tissue-specific manner.
  • Claudins are implicated in epithelial to mesenchymal transition (EMT), cancer stem cell (CSC) formation, and chemoresistance.
  • A claudin-low breast cancer subtype, marked by EMT and stem-like features, predicts tumor recurrence.

Conclusions:

  • Claudins are critical players in tumor progression and are associated with chemoresistance and recurrence.
  • Claudins represent promising therapeutic targets for developing treatments against chemoresistant and recurrent cancers.
  • Epigenetic therapies targeting claudins may offer new avenues for cancer treatment.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cell Adhesion Molecules - Types and Functions01:20

Cell Adhesion Molecules - Types and Functions

Cell adhesion molecules (CAMs) are pivotal to multicellularity and the coordinated functioning of tissues and organ systems. They enable physical interactions between cells and provide mechanical strength to tissues. They also function as receptors for signal transmission across the plasma membrane. The CAMs are broadly classified into four families - integrins, cadherins, selectins, and immunoglobulin-like CAMs (IgCAMs).
CAM Families
The Integrin family of proteins is primarily  involved in a...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...